-
Mashup Score: 4How mis-splicing of coenzyme A synthase impacts erythroid differentiation in SF3B1-mutated MDS - 1 year(s) ago
Kevin Rouault-Pierre, BSc, MSc, PhD, Barts Cancer Institute, London, UK, shares some insights into a study which investigated how the…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 1Comparing the ICC and WHO classifications for secondary AML and their impact on clinical practice - 1 year(s) ago
In this video, Enrico Attardi, MD, University of Rome Tor Vergata, Rome, Italy, shares some insights into the two classifications…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ISAL2023 | Check out our exclusive interview with @enrico_attardi, who gives an overview of the ICC & WHO classifications for secondary AML, their differences & impacts on clinical practice: 🎥 https://t.co/SaU8adiZFn #AMLsm #LeuSM #HemOnc
-
-
Mashup Score: 0
Hi, I’m Charlie Craddock from Birmingham, UK, and I’m with my great colleague and friend Chris Hourigan from NIH in the United States. And we’re at the ISAL AML meeting. So Chris, a lot of the talk at this meeting is about the emerging and increasingly important role of transplant in the management of fit adults with AML. And there’s a lot of thought about how we improve transplant outcomes. And…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
At #ISAL2023, we filmed a lovely discussion with @charliecraddock & @DrChrisHourigan, who discussed: ➡️ The importance of transplant in AML & improving outcomes ➡️ The value of pre-transplant MRD ➡️ The pre-MEASURE study & more! 👉 https://t.co/vkT4Wd7B2D 👈 #AMLsm #LeuSM https://t.co/ivioThsXV7
-
-
Mashup Score: 0Novel techniques being used for MRD assessment in AML & the importance of considering oligoclonality - 1 year(s) ago
Jacqueline Cloos, PhD, Amsterdam UMC, Amsterdam, The Netherlands, shares some insights into the importance of considering oligoclonality when assessing measurable…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Check out our interview with Jacqueline Cloos (@amsterdamumc), who discusses novel techniques being explored to assess MRD in AML & the importance of oligoclonality: 🎥 https://t.co/Ug8n4k5GXq #ISAL2023 #AMLsm #LeuSM #ISALXVIII #MRD #HemOnc
-
-
Mashup Score: 0Using a genome-wide CRISPR screen to evaluate mechanisms of resistance to FLT3 inhibitors in AML - 1 year(s) ago
Jian Huang, MD, PhD, Coriell Institute for Medical Research, Camden, NJ, shares some insights into a study which used genome-wide…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Jian Huang (@Coriell_Science) shares some insights into a study which used a genome-wide CRISPR screen to evaluate underlying mechanisms of resistance to FLT3 inhibitors in AML: 🎥 https://t.co/0dv134DvoO #ISAL2023 #HemOnc #AMLsm #LeuSM
-
-
Mashup Score: 3The importance of fitness assessment to improve treatment selection in patients with AML - 1 year(s) ago
Raffaele Palmieri, MD, University of Rome “Tor Vergata”, Rome, Italy, explains how assessing patient fitness is crucial to select the…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ISAL2023 | @RafPalmieri discusses the importance of assessing patient fitness when selecting treatment approaches in AML: 🎥 https://t.co/QzhZw0L7ff #LeuSM #AMLsm #HemOnc
-
-
Mashup Score: 0ISAL 2023 | VJHemOnc - 1 year(s) ago
The 18th International Symposium on Acute Leukemias 19–22 March 2023 | Munich, Germany / Online The 18th International Symposium on Acute Leukemias (ISALXVIII) took place on March 19-22, 2023 in Munich, Germany, and online, and covered the most exciting updates in the biology and treatment of acute myeloid…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
Last week, we had the pleasure of being in Munich at #ISAL2023, interviewing experts in AML and ALL, who shared some interesting insights & updates. Check out our interviews here: 🎥: https://t.co/0OhZz1tJdh #AMLsm #ALLsm #LeuSM #ImmunoOnc #HemOnc #ISALXVIII https://t.co/gIEUI4cgxQ
-
-
Mashup Score: 1
Ravi Majeti, MD, PhD, Stanford University, Stanford, CA, comments on the use of chromatin biology methods to understand the processes…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ISAL2023 | @RaviMajetiMD of @Stanford shares some insights into how epigenetic analysis may be used to better understand the biology of relapse in patients with AML. Watch here: 👉https://t.co/7gjMjaQpZ6👈 #AMLsm #LeuSM #HemOnc
-
-
Mashup Score: 0
Marion Subklewe, MD, Ludwig-Maximilians University, Munich, Germany, shares some insights into the current status of T-cell bispecific antibodies in the…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
#ISAL2023 | @MSubklewe of @LMU_Muenchen shares some insights into the current status of bispecifics in AML and challenges to overcome. Watch here: 👉https://t.co/ZLt7avBQrT👈 #AMLsm #LeuSM #ImmunoOnc #HemOnc
-
-
Mashup Score: 5
Farhad Ravandi, MD, The University of Texas MD Anderson Cancer Center, Houston, TX, discusses the promise of CD123-directed immunotherapy in…
Source: VJHemOncCategories: Hem/Onc News and Journals, Latest HeadlinesTweet-
There have been some exciting developments in AML with CD123-directed immunotherapy! Watch our interview with @fravandi1 of @MDAndersonNews to learn about promising agents currently under investigation: 🎥 https://t.co/urfUFic27e #AMLsm #LeuSM #ImmunoOnc #ISAL2023
-
#ISAL2023 | @kevin_rouault highlights recent research which discovered how mis-splicing of coenzyme A synthase impacts erythroid differentiation in SF3B1-mutated MDS & that vitamin B5 may be used to restore cells: 👉 https://t.co/ky01ltaTc7 👈 #MDSsm #HemOnc